SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001104659-11-019383
Filing Date
2011-04-11
Accepted
2011-04-11 07:32:17
Documents
5
Effectiveness Date
2011-04-11

Document Format Files

Seq Description Document Type Size
1 DEFA14A a11-7480_3defa14a.htm DEFA14A 36202
2 GRAPHIC g74803bei001.gif GRAPHIC 89035
3 GRAPHIC g74803bei002.gif GRAPHIC 84835
4 GRAPHIC g74803bei003.gif GRAPHIC 49264
5 GRAPHIC g74803bei004.gif GRAPHIC 45722
  Complete submission text file 0001104659-11-019383.txt   408336
Mailing Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069
Business Address 111 BARCLAY BLVD STE 280 LINCOLNSHIRE IL 60069 8474780500
BIOSANTE PHARMACEUTICALS INC (Filer) CIK: 0001023024 (see all company filings)

IRS No.: 582301143 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-31812 | Film No.: 11751566
SIC: 2836 Biological Products, (No Diagnostic Substances)